XML 64 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) - Successor - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash $ 160,711 $ 176,421
Accounts receivable, net of allowance for bad debt of $94,150 and $0 1,049,628 1,022,500
Royalty receivable 50,250 0
Inventory, net of allowance for obsolescence of $66,119 and $484 799,818 465,314
Prepaid other - related party 335,876 0
Prepaid and other assets 92,656 26,446
Total current assets 2,488,939 1,690,681
Long-term assets    
Property, plant and equipment, net of accumulated depreciation of $66,937 and $511 205,110 18,777
Right of use assets - operating leases 613,531 0
Intangible assets, net of accumulated amortization of $569,332 and $0 1,005,442 0
Total long-term assets 1,824,083 18,777
Total assets 4,313,022 1,709,458
Current liabilities    
Accounts payable 216,976 156,727
Accounts payable - related party 188,228 36,203
Accrued royalties and payables 481,598 228,606
Accrued bonus and commissions 1,148,123 701,125
Operating lease liability - current 112,611 0
Line of credit 2,000,000 0
Total current liabilities 4,147,536 1,122,661
Long-term liabilities    
Operating lease liability - long term 511,829 0
Convertible notes payable - related party 1,500,000 0
Accrued interest - related party 83,760 0
Total long-term liabilities 2,095,589 0
Total liabilities 6,243,125 1,122,661
Shareholders' equity (deficit)    
Series F Convertible Preferred Stock: $10 par value, 1,200,000 shares authorized; 1,136,815 issued and outstanding as of September 30, 2019 and 1,136,815 issued and outstanding as of December 31, 2018 11,368,150 11,368,150
Common Stock: $0.001 par value, 20,000,000 shares authorized; 2,366,181 issued and outstanding as of September 30, 2019 and none issued and outstanding as of December 31, 2018 2,366 0
Additional paid-in capital (12,080,629) (10,919,639)
Retained earnings (accumulated deficit) (1,212,679) 138,286
Total Sanara MedTech shareholders' equity (deficit) (1,922,792) 586,797
Equity attributable to noncontrolling interest (7,311) 0
Total shareholders' equity (deficit) (1,930,103) 586,797
Total liabilities and shareholders' equity $ 4,313,022 $ 1,709,458